Human Albumin Grifols 5% in plasmapheresis: a new therapy involving beta-amyloid mobilisation in Alzheimer's disease

Human Albumin Grifols 5% in plasmapheresis: a new therapy involving beta-amyloid mobilisation in Alzheimer's disease

 Removing beta-amyloid from the circulation may have beneficial effects in Alzheimer's disease.

Enhanced by Zemanta

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)